Guaifenesin
- Product NDC
- 60687-852
- 11-digit product format
- 606870852
- Labeler code
- 60687
- Product ID
- 60687-852_24b1b6f4-c113-8adc-e063-6394a90a546c
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2024-10-20
- Substance
- GUAIFENESIN
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310604 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2fd702ea-3069-472c-b99e-c527f1375705 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-852-17 | Guaifenesin | 10 in 1 CASE | SOLUTION | 10 | 1 | |
| 60687-852-40 | Guaifenesin | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 | |
| 60687-852-46 | Guaifenesin | 10 in 1 TRAY | SOLUTION | 10 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60687-852-17 | ML - Milliliter | 60687-852 | 4a65c2b5-de11-422b-83ae-f0f3e9d71468 | 1 | 2024-11-05 |
| 60687-852-40 | ML - Milliliter | 60687-852 | 459738a7-6ab0-4aa9-b321-6b3515eb703e | 1 | 2024-11-05 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks DayQuil and Vicks NyQuil HIGH BLOOD PRESSURE COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | efbda62c-5d1a-2026-e053-2995a90a95d7 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil HIGH BLOOD PRESSURE Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | d83c4691-785d-d1a0-e053-2995a90ad196 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil VapoCOOL COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | 32819644-9f07-9f70-e063-6294a90a7223 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil Kids COLD and COUGH plus FEVER | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 1a01b294-a5ee-ab35-e063-6394a90a4a1a | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil Kids and Vicks NyQuil Kids COLD and COUGH plus FEVER | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 2d430264-074d-fb22-e063-6294a90a57f6 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil Kids COLD and COUGH plus FEVER | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 1a01d4f7-37ed-bb92-e063-6294a90a208c | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | efb982d4-93d0-815f-e053-2995a90a82dd | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | efe4e649-7514-32dd-e053-2995a90a0492 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil and Vicks NyQuil COLD and FLU | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | efb92829-1007-1c5d-e053-2a95a90a3c9b | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil and Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 04dc3835-64be-d9e4-e063-6394a90a8599 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | fc9a43d8-0359-9def-e053-6294a90a7e91 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | fc9a6f7e-32c1-9ded-e053-6294a90a9dcc | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil and Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 416c6674-e4aa-6375-e054-00144ff8d46c | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | fc9e05a5-ca03-faa2-e053-6294a90a0d58 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil FOR PEOPLE WITH DIABETES COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 16272e93-0062-935a-e063-6294a90a0dda | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil and Vicks NyQuil FOR PEOPLE WITH DIABETES COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 17dfc247-fcb6-9659-e063-6294a90a2523 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil FOR PEOPLE WITH DIABETES COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 16275c74-32a6-25f4-e063-6394a90a6717 | 2026-10-05 | Warnings | M012 |
| Vicks VapoDrops | MENTHOL | The Procter & Gamble Manufacturing Company | 3c431baa-c49d-ff3f-e063-6394a90aa12a | 2026-10-05 | Warnings | M012 |
| VICKS FORMULA 44DM COUGH | DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 05411a51-a49a-96fd-e063-6294a90ae37b | 2026-10-05 | Warnings | M012 |
| VICKS FORMULA 44DM COUGH and CHEST CONGESTION | DEXTROMETHORPHAN HBR, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 05412b91-c1f0-c947-e063-6294a90acd17 | 2026-10-05 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310604 | guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 20 MG/ML Oral Solution | SCD | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Solution | SY | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Syrup | SY | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 200 MG per 10 ML Oral Solution | SY | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 300 MG per 15 ML Oral Solution | SY | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 400 MG per 20 ML Oral Solution | SY | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 60687-852-17 | 60687085217 | 10 TRAY in 1 CASE (60687-852-17) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-852-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-852-40) | 10 tray | 2024-10-20 | No | No | Current |
| 60687-852-40 | 60687085240 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | |||
| 60687-852-46 | 60687085246 | 10 in 1 TRAY | Historical |